However, recent studies have shown that SPON2 is upregulated in various carcinomas including colorectal carcinoma, hepatocellular carcinoma, laryngeal squamous cell carcinoma, and gastric cancer, as well as prostate cancer [15,16,17,18]. The gene discussed is SPON2; the disease is prostate cancer.